Get CEO.CA Pro
Real-time Level 2 Market Depth
Click for live demo
back
news releases
21 Oct 2024, 09:19
CORRECTION - NanoXplore to Host a Webcast to Discuss First Quarter Results on November 7th, 2024 $GRA $NNXPF.US
CORRECTION - NanoXplore to Host a Webcast to Discuss First Quarter Results on November 7th, 2024 $GRA $NNXPF.US
21 Oct 2024, 07:30
NanoXplore to Host a Webcast to Discuss First Quarter Results on November 7th, 2024 $GRA $NNXPF.US
NanoXplore to Host a Webcast to Discuss First Quarter Results on November 7th, 2024 $GRA $NNXPF.US
18 Sep 2024, 17:15
NanoXplore Reports Results for Its Q4-2024 and Full Year 2024 $GRA $NNXPF.US
NanoXplore Reports Results for Its Q4-2024 and Full Year 2024 $GRA $NNXPF.US
4 Sep 2024, 07:15
NanoXplore to Host a Webcast to Discuss Fourth Quarter and Year End Results on September 19, 2024 $GRA $NNXPF.US
NanoXplore to Host a Webcast to Discuss Fourth Quarter and Year End Results on September 19, 2024 $GRA $NNXPF.US
show more ▾
featured articles
October 31, 2024
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems $BIOV
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems $BIOV
October 31, 2024
Gold bull market signals
Gold bull market signals
October 31, 2024
Lithium ION Energy Signs LOI with United Rare Earths, for a Business Combination $IONGF.US $ION
Lithium ION Energy Signs LOI with United Rare Earths, for a Business Combination $IONGF.US $ION
October 31, 2024
PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases $LMLLF.US $PHRX
PharmaDrug's Sairiyo Therapeutics Announces Successful Completion of Stability Study of PD-001 (Patented Reformulated Cepharanthine) to Support Use in Phase 1 Study for Viral Infectious Diseases $LMLLF.US $PHRX
show more ▾
CEO.CA Chairman's Briefing
Global Markets. Mining Trends. Every Thursday.
read first
Please read the CEO.CA House Rules before posting.
social
legal
Use of this site indicates acceptance of the
Privacy Policy
and
Terms of Use.
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
CEO.CA members discuss high-risk penny stocks which can lose their entire value. Only risk what you can afford to lose.
© 2022 - CEO.CA Technologies Ltd.
NanoXplore Inc.
GRA.TO
$GRA ↻
1 online
Today
This week
Search
Subscribe
Sign up to become a contributing member of the community.
Trending
Personal channels
